Summary of Consolidated Financial Results for Second Quarter of FY2021

1. Summary of Operating Results

2nd Q of

2nd Q of

Incr.

FY2020

FY2021

(Decr.)

Sales revenue

537.0

743.5

206.5

Operating income before special items

18.6

94.3

75.7

Operating income

17.9

94.5

76.6

Net income

11.0

78.9

67.9

Net income attributable to owners of the parent

9.6

73.9

64.3

2. Sales Revenue and Operating Income before Special Items by Business SegmentSales revenue

2nd Q of

2nd Q of

Incr.

Breakdown

FY2020

FY2021

(Decr.)

Volume

Price

Mobility

132.0

191.1

59.1

30.9

28.2

Health Care

66.0

80.9

14.9

14.6

0.3

Food & Packaging

89.6

107.0

17.4

15.9

1.5

Basic Materials

242.6

357.4

114.8

13.8

101.0

Others

6.8

7.1

0.3

-

0.3

Total

537.0

743.5

206.5

75.2

131.3

Nov 5, 2021

Mitsui Chemicals, Inc.

Unit : Billions of Yen)

FY2020

(announced Nov. 5)

FY2021

Incr. (Decr.)

1,211.7

1,630.0

418.3

85.1

160.0

74.9

78.1

145.0

66.9

64.2

114.0

49.8

57.9

103.0

45.1

Unit : Billions of Yen)

Forecast for FY2021

FY2020

(announced Nov. 5)

FY2021

Incr. (Decr.)

315.5

435.0

119.5

143.9

165.0

21.1

197.7

230.0

32.3

541.4

786.0

244.6

13.2

14.0

0.8

1,211.7

1,630.0

418.3

Operating income before special items

Unit : Billions of Yen)

2nd Q of

2nd Q of

Incr.

Breakdown

Forecast for FY2021

FY2020

(announced Nov. 5)

Fixed

FY2020

FY2021

(Decr.)

Volume

Price*

Costs

FY2021

Incr. (Decr.)

etc.

30.2

50.0

19.8

Mobility

8.2

24.1

15.9

8.8

7.2

(0.1)

19.9

21.5

1.6

Health Care

7.2

10.9

3.7

8.4

(1.5)

(3.2)

22.0

27.0

5.0

Food & Packaging

9.5

12.7

3.2

5.7

(1.8)

(0.7)

19.6

72.5

52.9

Basic Materials

(4.6)

48.6

53.2

3.5

38.7

11.0

(1.1)

(2.0)

(0.9)

Others

(0.3)

(0.2)

0.1

-

-

0.1

(5.5)

(9.0)

(3.5)

Adjustment

(1.4)

(1.8)

(0.4)

-

-

(0.4)

85.1

160.0

74.9

Total

18.6

94.3

75.7

26.4

42.6

6.7

*Price includes both selling and purchasing price variances.

3. Summary of Statement of Financial Position

Unit : Billions of Yen)

Assets

Liabilities and Equity

As of

As of

Incr.

As of

As of

Incr.

Mar. 31,

Sept. 30,

Mar. 31,

Sept. 30,

(Decr.)

(Decr.)

2021

2021

2021

2021

Current assets

787.6

903.3

115.7

Interest-bearing liabilities

563.8

562.2

(1.6)

Property, plant and equipment

502.0

535.2

33.2

Other liabilities

312.2

365.5

53.3

& right-of-use assets

Goodwill and intangible assets

20.8

26.8

6.0

Equity attributable to owners of

607.9

677.7

69.8

the parent

Other non-current assets

247.7

227.1

(20.6)

Non-controlling interests

74.2

87.0

12.8

Total assets

1,558.1

1,692.4

134.3

Total liabilities and equity

1,558.1

1,692.4

134.3

Inventories

258.8

310.5

51.7

Net D/E Ratio

0.60

0.54

(0.06)

4. Summary of Statement of Cash Flows

Unit : Billions of Yen)

2nd Q of

2nd Q of

Incr.

FY2020

(announced Nov. 5)

FY2020

FY2021

(Decr.)

FY2021

Incr. (Decr.)

Cash flows from operating activities

111.1

62.6

(48.5)

174.3

144.0

(30.3)

Cash flows from investing activities

(39.4)

(39.5)

(0.1)

(77.5)

(175.0)

(97.5)

Free cash flows

71.7

23.1

(48.6)

96.8

(31.0)

(127.8)

Cash flows from financing activities

(5.7)

(23.4)

(17.7)

(69.0)

27.0

96.0

Others

(1.0)

1.1

2.1

3.6

0.0

(3.6)

Net incr.(decr.) in cash and cash equivalents

65.0

0.8

(64.2)

31.4

(4.0)

(35.4)

Cash and cash equivalents at the end of period

229.6

196.8

(32.8)

196.0

0.0

5. Accounting Fundamentals

Forecast for FY2021

2nd Q of

2nd Q of

Incr.

FY2020

(announced Nov. 5)

FY2020

FY2021

(Decr.)

FY2021

Incr. (Decr.)

R & D expenses

Billions

16.3

17.8

1.5

33.8

39.0

5.2

Depreciation & amortization

Billions

37.9

39.8

1.9

76.6

83.0

6.4

Capital expenditures

Billions

41.5

93.2

51.7

93.2

137.0

43.8

Financing incomes & expenses

Billions

(2.2)

(2.1)

0.1

(3.2)

(6.0)

(2.8)

Interest-bearing liabilities

Billions

606.5

562.2

(44.3)

563.8

627.0

63.2

Net D/E Ratio

percentage

0.68

0.54

(0.14)

0.60

0.63

0.03

Number of employees

person

18,155

18,593

438

18,051

19,000

949

Exchange rate

Yen / US$

107

110

3

106

112

6

Domestic standard naphtha price

Yen / KL

27,600

50,600

23,000

31,300

55,300

24,000

Number of group companies

company

152

154

2

154

163

9

6. Dividends

Annual Dividends per Share (yen)

1st Q

Interim

3rd Q

Year-end

Annual

(2nd Q)

(4th Q)

FY2020 Result

-

50.00

-

50.00

100.00

FY2021 Result/Forecast

-

55.00

-

55.00

110.00

7. Number of Shares Outstanding (common stock)

FY2020

2nd Q of

FY2021

Number of shares outstanding at term-end (including treasury stock)

204,608,615

204,653,315

Number of shares of treasury stock at term-end

8,664,390

9,568,473

Average number of shares

192,454,789 *

195,795,294

*2nd Q of FY2020

1. Operating Results

  1. Overview

In the fiscal period under review (the six-month period from Apr 1, 2021 to Sept 30, 2021, hereinafter the "first half"), although the global spread of the coronavirus continued to remain, there were signs of the economic recovery due to wide availability of vaccines mainly in developed countries. In Japan as well, the economy continued to be impacted by the spread of the coronavirus but signs of recovery were visible mainly in the manufacturing sector, as the vaccination has expanded. On the other hand, the economy suffered increase of crude oil prices and deceleration of automotive production, which must be carefully monitored.

The Mitsui Chemicals Group (hereafter "the Group") reported the following operating results for the first half as follows. The Group has applied operating income before special items as a management indicator, which is operating income excluding non-recurring items.

(Billions of Yen)

Operating Income

Net Income

Attributable to

Sales Revenue

before Special

Operating Income

Owners of the

Items

Parent

First half

743.5

94.3

94.5

73.9

Same period of

537.0

18.6

17.9

9.6

previous fiscal year

Difference

206.5

75.7

76.6

64.3

Ratio (%)

38.5

407.6

427.9

670.1

Sales revenue increased 206.5 billion yen, or 38.5%, compared with the corresponding period of the previous fiscal year to 743.5 billion yen. This was mainly attributable to increase in sales prices due to higher naphtha and other raw materials and fuel prices, in addition to higher sales volume in each segment as economic activities have resumed.

Operating income before special items was 94.3 billion yen, an increase of 75.7 billion yen or 407.6% year on year. This result was due to favorable terms of trade as a result of higher overseas market prices of Bisphenol A, in addition to higher sales volume in each segment and improved share of profit (loss) of investments accounted for using equity method.

Operating income was 94.5 billion yen, increased 76.6 billion yen or 427.9% year on year. This result was mainly due to the increase of operating income before special items.

Financial income/expenses improved 0.1 billion yen year on year to 2.1 billion yen loss, due to improved foreign exchange gains and losses, although reversal of allowance for doubtful accounts in the corresponding period of the previous fiscal year was no longer booked.

As a result of the aforementioned factors, income before income taxes amounted to 92.4 billion yen, an increase of 76.7 billion yen or 486.5% year on year.

Net income attributable to owners of the parent after accounting for income taxes and non-controlling interests was 73.9 billion yen, an increase of 64.3 billion yen or 670.1% compared with the corresponding period of the previous fiscal year. Basic earnings per share for the period were 377.64 yen.

- 1 -

  1. Results by Business Segment

The status of each segment during the first half is as follows.

Mobility

Sales revenue increased 59.1 billion yen compared with the corresponding period of the previous fiscal year to 191.1 billion yen and comprised 26% of total sales. Operating income before special items increased 15.9 billion yen to 24.1 billion yen year on year. The increase in income was due to recovery of production volume in automotive industry.

In elastomers, performance compounds and overseas polypropylene compound, the Group captured demand and sales remained healthy.

In performance polymers, the Group captured demand and sales remained healthy for ICT-related products.

In solution business, sales remained same level as the corresponding period of the previous fiscal year due to prolonged delay of the development of prototyping.

Health Care

Sales revenue increased 14.9 billion yen year on year to 80.9 billion yen and comprised 11% of total sales. Operating income before special items increased 3.7 billion yen to 10.9 billion yen, mainly due to healthy sales in vision care materials.

In vision care materials, the Group captured demand and sales remained healthy for ophthalmic lens materials.

In nonwoven fabrics, sales of masks stayed healthy but sales of medical gowns have declined.

In dental materials, the Group captured demand and sales remained healthy mainly in Europe.

Food & Packaging

Sales revenue increased 17.4 billion yen compared with the same period of the previous fiscal year to 107.0 billion yen and comprised 14% of total sales. Operating income before special items increased 3.2 billion yen to 12.7 billion yen year on year, due to healthy sales in coatings & engineering materials and performance films and sheets.

In coatings & engineering materials, the Group captured demand and sales remained firm.

In performance films and sheets, sales were mainly firm in ICT-related industrial films and sheets.

In agrochemicals, overseas sales were healthy.

Basic Materials

Sales revenue increased 114.8 billion yen compared with the same period of the previous fiscal year to 357.4 billion yen and accounted for 48% of total sales. Operating income before special items increased 53.2 billion yen to 48.6 billion yen, due to higher overseas market of prices of Bisphenol A and inventory revaluation gain, which was resulting from the higher naphtha and raw material prices.

Naphtha cracker operating rates were higher than the same period of the previous fiscal year due to increased demand of downstream products. Sales of polyethylene and polypropylene were affected by higher demand in the domestic economy.

- 2 -

Others

Sales revenue increased 0.3 billion yen compared with the same period of the previous fiscal year to 7.1 billion yen and comprised 1% of total sales. Operating income before special items was 0.2 billion yen loss, increase of 0.1 billion yen compared to the same period of the previous year.

2. Financial Position

  1. Status of Assets, Liabilities and Net Assets

Total assets at the end of the first half stood at 1,692.4 billion yen, an increase of 134.3 billion yen compared with the end of the previous fiscal year.

Total liabilities at the end of first half increased 51.7 billion yen compared with the previous fiscal year-end to 927.7 billion yen. Interest-bearing debt amounted to 562.2 billion yen, a decrease of 1.6 billion yen compared with the previous fiscal year-end. As a result, the interest-bearing debt ratio was 33.2%, a decrease of 3.0 percentage point.

Total equity was 764.7 billion yen, an increase of 82.6 billion yen compared with the previous fiscal year-end. The ratio of equity attributable to owners of the parent was 40.0%, an increase of 1.0 percentage point.

Accounting for the aforementioned factors, the net debt-equity ratio stood at 0.54 at the end of the fiscal year, 0.06 point decrease from the previous fiscal year-end.

  1. Cash Flow Status

Cash and cash equivalents (hereafter called "net cash") at the end of the first half increased 0.8 billion yen to 196.8 billion yen compared with the previous fiscal year-end.

Cash Flows from Operating Activities

Net cash provided by operating activities decreased 48.5 billion yen to 62.6 billion yen due to increase of working capital, despite of higher income before income taxes.

Cash Flows from Investing Activities

Net cash used in investing activities increased 0.1 billion yen to 39.5 billion yen due to increase of cash outflows from capital expenditure, despite of proceeds of shares of subsidiaries.

Cash Flows from Financing Activities

Net cash used in financing activities increased 17.7 billion yen to 23.4 billion yen due primarily to increase of repayments of interest-bearing debt.

3. Forecast for Fiscal 2021 (Year Ending March 31, 2022)

(1) Overview

Revised financial forecasts are based on the following assumptions:

  1. Exchange rate for the full year is 112 yen/US$ (Oct - Mar:114 yen/US$)
  2. Average price of domestic naphtha is 55,300 yen/kl (Oct - Mar:60,000 yen/kl)

Based on the Group's performance in the first half, incomes are expected to be higher than previously announced due to higher overseas market prices of Bisphenol A.

- 3 -

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Mitsui Chemicals Inc. published this content on 05 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 November 2021 04:21:19 UTC.